A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
FindCure Biosciences (ZhongShan) Co., Ltd.
Hoffmann-La Roche
Endeavor Biomedicines, Inc.
M.D. Anderson Cancer Center
University of California, Irvine
Eastern Cooperative Oncology Group
ViroMissile, Inc.
Kaiser Permanente
MacroGenics
Avacta Life Sciences Ltd
Institut Curie
City of Hope Medical Center
Fred Hutchinson Cancer Center
Solve Therapeutics
Perspective Therapeutics
Ocellaris Pharma, Inc.
Eli Lilly and Company
Var2 Pharmaceuticals
Hoffmann-La Roche
UNICANCER
University of Illinois at Chicago
Tanabe Pharma America, Inc.
National Cancer Institute (NCI)
HiFiBiO Therapeutics
Bayer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
M.D. Anderson Cancer Center
British Columbia Cancer Agency
Epkin
Jonsson Comprehensive Cancer Center
Turning Point Therapeutics, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
University of California, Irvine
Eli Lilly and Company
Cancer Research UK
Instituto do Cancer do Estado de São Paulo
Hutchmed
Elevation Oncology
Intensity Therapeutics, Inc.
Cedars-Sinai Medical Center
Rutgers, The State University of New Jersey
Cyteir Therapeutics, Inc.
University of California, Davis
University Medical Center Groningen
TopAlliance Biosciences